
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $257.6M | -- | -- | $7.20 | -- |
08/05/2025 | Q2 | $247.3M | -- | -- | $6.66 | -- |
05/13/2025 | Q1 | $242M | $253.3M | $6.13 | $6.44 | -$0.31 |
02/10/2025 | Q4 | -- | $258.2M | $4.74 | $6.52 | -$1.78 |
11/12/2024 | Q3 | $258M | $256.2M | $6.30 | $6.78 | -$0.48 |
08/05/2024 | Q2 | $237.9M | $246.3M | $7.23 | $6.92 | $0.32 |
05/28/2024 | Q1 | $248M | $253.4M | $7.68 | $7.75 | -$0.07 |
02/13/2024 | Q4 | $245.7M | $249.3M | $7.67 | $7.79 | -$0.12 |
11/13/2023 | Q3 | $219M | $239.2M | $6.76 | $7.36 | -$0.60 |
08/07/2023 | Q2 | $227.4M | $241.5M | $7.32 | $6.93 | $0.40 |
05/15/2023 | Q1 | -- | $243.6M | $7.18 | -- | -- |
02/14/2023 | Q4 | -- | $252.5M | $7.53 | -- | -- |
11/08/2022 | Q3 | -- | $260M | $3.29 | -- | -- |
08/01/2022 | Q2 | -- | $250.9M | $0.40 | -- | -- |
05/16/2022 | Q1 | -- | $229.9M | $16.00 | -- | -- |
02/07/2022 | Q4 | -- | $215M | $8.04 | -- | -- |
11/08/2021 | Q3 | -- | $195.9M | $10.55 | -- | -- |
08/02/2021 | Q2 | -- | $146.4M | $18.10 | -- | -- |
05/10/2021 | Q1 | -- | $132.1M | $14.47 | -- | -- |
02/16/2021 | Q4 | -- | $119.6M | $2.00 | -- | -- |
11/05/2020 | Q3 | -- | $118.9M | $1.73 | -- | -- |
08/03/2020 | Q2 | -- | $116.8M | $1.55 | -- | -- |
05/18/2020 | Q1 | -- | $106.2M | $1.17 | -- | -- |
02/10/2020 | Q4 | -- | $110.2M | $1.73 | -- | -- |
11/04/2019 | Q3 | -- | $111.8M | $2.20 | -- | -- |
08/05/2019 | Q2 | -- | $112.3M | $1.97 | -- | -- |
05/13/2019 | Q1 | -- | $112.9M | $2.19 | -- | -- |
02/19/2019 | Q4 | -- | $115.6M | -$19.25 | -- | -- |
11/14/2018 | Q3 | -- | $117.8M | $10.76 | -- | -- |
09/24/2018 | Q2 | -- | $113.5M | $0.74 | -- | -- |
06/26/2018 | Q1 | -- | $111.9M | $1.91 | -- | -- |
02/12/2018 | Q4 | -- | $114.2M | $2.86 | -- | -- |
10/30/2017 | Q3 | -- | $113.6M | $2.80 | -- | -- |
07/31/2017 | Q2 | -- | $113.9M | $2.52 | -- | -- |
05/30/2017 | Q1 | -- | $110.1M | $2.38 | -- | -- |
02/21/2017 | Q4 | -- | $112.1M | -$56.98 | -- | -- |
12/16/2016 | Q3 | -- | $111.8M | -$1.12 | -- | -- |
08/02/2016 | Q2 | -- | $137M | $5.74 | -- | -- |
05/04/2016 | Q1 | -- | $137.5M | $5.60 | -- | -- |
02/16/2016 | Q4 | -- | $143.3M | $0.84 | -- | -- |
11/03/2015 | Q3 | -- | $144.5M | $5.32 | -- | -- |
Danaos reported $253.3M worth of top line sales in its most recent quarter.
Danaos announced earnings per share of $6.13 which represents a miss of analyst forecast a $6.44 per share.
Danaos reported $143.4M that represents $7.64 per share over the last quarter.
Danaos's earnings are forecast to grow from $26.05 per share to $26.88 per share next year representing an increase of 2.9%.
Danaos's next earnings date is August 5, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.